Overview
The primary objective of this study is to characterize safety and tolerability of romosozumab in postmenopausal women with osteoporosis and a high risk of fracture in India.
Eligibility
Inclusion Criteria:
- Participants diagnosed with osteoporosis who are postmenopausal and have a high risk of fracture who provided inform consent (in-person or through their legally authorized representative) to participate in the use of romosozumab per local label in India.
Exclusion Criteria:
- Participants who experienced myocardial infarction or stroke within a year prior to entering this study.